Renaissance Technologies (RenTech)'s FENC Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 134,200 shares of Fennec Pharmaceuticals Inc. (FENC) worth $1.44 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in FENC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 139,900 shares. Largest reduction occurred in Q2 2024, reducing 139,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Fennec Pharmaceuticals (FENC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fennec Pharmaceuticals (FENC) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +134,200 | New Buy | 134,200 | $10.75 |
| Q1 2026 | -20,000 | Sold Out | 0 | $0.00 |
| Q4 2025 | +9,400 | Add 88.68% | 20,000 | $7.70 |
| Q3 2025 | +10,600 | New Buy | 10,600 | $9.36 |
| Q2 2024 | -139,900 | Sold Out | 0 | $0.00 |
| Q1 2024 | +139,900 | New Buy | 139,900 | $11.12 |
| Q3 2021 | -20,284 | Sold Out | 0 | $0.00 |
| Q2 2021 | +20,284 | New Buy | 20,284 | $7.30 |
| Q3 2020 | -134,000 | Sold Out | 0 | $0.00 |
| Q2 2020 | +57,904 | Add 76.09% | 134,000 | $8.35 |
| Q1 2020 | +52,296 | Add 219.73% | 76,096 | $5.94 |
| Q4 2019 | +23,800 | New Buy | 23,800 | $6.47 |
| Q2 2019 | -31,100 | Sold Out | 0 | $0.00 |
| Q1 2019 | +31,100 | New Buy | 31,100 | $4.86 |
| Q2 2018 | -34,800 | Sold Out | 0 | $0.00 |
| Q1 2018 | +34,800 | New Buy | 34,800 | $12.10 |
Renaissance Technologies (RenTech)'s Fennec Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Fennec Pharmaceuticals Inc. (FENC) in Q1 2018, acquiring 34,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Fennec Pharmaceuticals Inc. (FENC) for 16 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Fennec Pharmaceuticals Inc. (FENC) was in Q1 2024, adding 139,900 shares worth $1.56 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 134,200 shares of Fennec Pharmaceuticals Inc. (FENC), valued at approximately $1.44 M.
As of the Q2 2026 filing, Fennec Pharmaceuticals Inc. (FENC) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Fennec Pharmaceuticals Inc. (FENC) was 139,900 shares, as reported at the end of Q1 2024.